The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models - Concepedia

Concepedia

Publication | Closed Access

The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models

144

Citations

25

References

2011

Year

Emmanuel Normant, Guillermo Paez, Kip A. West, Alice R. Lim, Kelly L. Slocum, Chris Tunkey, James K. McDougall, Andrew A. Wylie, Keith Robison, K. Caliri,

OncologyEml4–alk LevelsAlk-driven Nsclc ModelsMedicineHsp90 Inhibitor Ipi-504Cancer Cell BiologyImmune Checkpoint InhibitorSystems BiologyCancer BiologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1

Page 1